Sort
82,697 grants matching “vaccine development”
Structural characterization of host-pathogen interactions
$780,221Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanisms of effective antibody neutralization
$780,221Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Structural vaccinology for infectious diseases
$780,221Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$780,197Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AI
Functional profiling of OSP-specific and other antibodies during shigella infection
$780,195Edward T. Ryan · Massachusetts General Hospital · R01 · FY2020 · AI
Salmonella Group C as part of a multivalent Salmonella vaccine
$780,174Sharon Mei Tennant · University Of Maryland Baltimore · U19 · FY2014 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$780,174William Ramses Bishai · Johns Hopkins University · R01 · FY2020 · AI
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$780,149Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2019 · AI
Prostate Section
$780,135Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children
$780,091Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Understanding the Regional Ecology of a Future HIV Vaccine
$780,044Dolores Albarracin · University Of Pennsylvania · R01 · FY2023 · MH
Development of a Self Inactivating, Highly Effective TB Vaccine
$780,015Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Linking the behavior of individual host cells to their transcriptional signatures
$780,000Lalita Ramakrishnan · University Of Washington · DP1 · FY2010 · OD
A revolutionary vaccine approach to prevent HIV infection in substance abuse
$780,000Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2018 · DA
A revolutionary vaccine approach to prevent HIV infection in substance abuse
$780,000Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2014 · DA
A revolutionary vaccine approach to prevent HIV infection in substance abuse
$780,000Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2017 · DA
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2023 · AI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2022 · AI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2021 · AI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2024 · AI
Non-human primate models of malarial anemia
$779,966Mary R Galinski · Northwestern University At Chicago · P01 · FY2007 · HL
Consequences of Chemokine-Receptor Interactions with Chemokines and Chemokine Mi
$779,932Joost J Oppenheim · Basic Sciences · Z01 · FY2007 · CA
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma
$779,909Pingsheng Wu · Vanderbilt University Medical Center · R01 · FY2024 · HL
Targeted Nano-enhanced Optical Delivery of opsin for dry-AMD therapy
$779,869Samarendra Kumar Mohanty · Nanoscope Technologies, Llc · R44 · FY2020 · EY
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
$779,817Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI